Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from peptidology.co, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 5-Amino-1MQ | 3 | 99.38% | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Glutathione | 1671 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| Semax | 1665 | Vanguard Laboratory | 99.39% | LALUSP<71>HM | — |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| Acetic Acid | 1 | 99.80% | — | — | — |
| BPC-157 | 6 | 99.58% | — | — | — |
| BPC-157/TB-500 | 6 | 99.62% | — | — | — |
| Cardiogen | 1 | 99.80% | — | — | — |
| Cartalax | 1 | 99.80% | — | — | — |
| Cibinetide | 1 | 99.80% | — | — | — |
| CJC-1295 no DAC | 2 | 99.69% | — | — | — |
| Cortagen | 1 | 99.80% | — | — | — |
| DSIP | 3 | 99.13% | — | — | — |
| Epitalon | 3 | 99.41% | — | — | — |
| Follistatin-334 | 1 | 99.50% | — | — | — |
| FOXO4-DRI | 1 | 99.80% | — | — | — |
| GHK-Cu | 7 | 99.75% | — | — | — |
| GHRP-2 | 1 | 99.03% | — | — | — |
| GLOW | 7 | 99.47% | — | — |
| GLP1-S | 2 | 99.81% | — | — | — |
| GLP2-T | 8 | 99.73% | — | — | — |
| GLP3-R | 14 | 99.71% | — | — |
| Glutathione | 2 | 99.80% | — | — | — |
| Gonadorelin | 1 | 99.16% | — | — | — |
| HGH Fragment 176-191 | 5 | 99.29% | — | — |
| IGF-LR3 | 2 | 99.69% | — | — | — |
| Ipamorelin | 5 | 99.61% | — | — | — |
| KLOW | 6 | 99.38% | — | — |
| KPV | 3 | 99.79% | — | — | — |
| LIPO-C | 1 | — | — | — | — | — |
| Livagen | 1 | 99.05% | — | — | — |
| LL-37 | 2 | 99.63% | — | — | — |
| Melanotan 1 | 1 | 99.80% | — | — | — | — |
| Melanotan 2 | 2 | 99.80% | — | — | — |
| MOTS-c | 8 | 99.37% | — | — | — |
| NAD+ | 6 | 99.12% | — | — | — |
| Pancragen | 1 | 99.02% | — | — | — |
| PE-22-28 | 1 | 99.69% | — | — | — |
| PEG MGF | 1 | 99.80% | — | — | — |
| Pinealon | 1 | 99.15% | — | — | — |
| PNC-27 | 1 | 99.60% | — | — |
| PT-141 | 2 | 99.18% | — | — | — |
| Selank | 3 | 99.39% | — | — | — |
| Semax | 4 | 99.44% | — | — | — |
| Semax/Selank | 2 | 99.44% | — | — | — |
| Sermorelin | 4 | 99.52% | — | — | — |
| SNAP-8 | 2 | 99.09% | — | — | — |
| SS-31 | 1 | 99.80% | — | — | — |
| Survodutide | 1 | 99.80% | — | — | — |
| TA-1/Thymulin | 1 | 99.70% | — | — | — |
| TB-500 | 4 | 99.50% | — | — | — |
| Tesamorelin | 3 | 99.36% | — | — | — |
| Tesamorelin/CJC-1295/Ipamorelin | 6 | 99.55% | — | — | — |
| Tesamorelin/Ipamorelin | 1 | 99.34% | — | — | — |
| Thymalin | 2 | 99.47% | — | — | — |
| Thymosin Alpha-1 | 4 | 99.64% | — | — | — |
| Vesugen | 1 | 99.53% | — | — | — |
| Vilon | 1 | 99.80% | — | — | — |
| VIP | 1 | 99.80% | — | — | — |
| View |
| GLP1-S | 120005 | TrustPointe Analytics | 99.82% | USP<71> | — | View |
| Thymosin Alpha-1 | 1364 | Vanguard Laboratory | 99.57% | LALUSP<71>HM | — | View |
| Ipamorelin | — | Vanguard Laboratory | 99.45% | LALHM | — | View |
| Tesamorelin/CJC-1295/Ipamorelin | 1672 | Vanguard Laboratory | 99.50% | LALUSP<71>HM | — | View |
| SS-31 | 1364 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| Thymosin Alpha 1 | 1356 | Vanguard Laboratory | 99.41% | LALUSP<71>HM | — | View |
| MOTS-c | 1356 | Vanguard Laboratory | 99.65% | LALUSP<71>HM | — | View |
| BPC-157 | 1670 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| CJC-1295/Ipamorelin | 01-018-PD-1358 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| MOTS-c | 1665 | Vanguard Laboratory | 99.04% | LALUSP<71>HM | — | View |
| Melanotan 1 | — | Vanguard Laboratory | 99.80% | LALUSP<71> | — | View |
| GLP2-T | 1667 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| GLP3-R | 01-073-PD-1354 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| Ipamorelin | 1665 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| CJC-1295 no DAC | 1670 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| Thymosin Alpha-1 | 1670 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| IGF-LR3 | 01-039-PD-1358 | Vanguard Laboratory | 99.75% | LALUSP<71>HM | — | View |
| KLOW | 1671 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| NAD+ | 1356 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| GLP3-R | 1670 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| GLP3-R | — | Vanguard Laboratory | 99.80% | LAL | — | View |
| Survodutide | 1671 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| Epitalon | 1359 | Vanguard Laboratory | 99.38% | LALUSP<71>HM | — | View |
| Tesamorelin | 1357 | Vanguard Laboratory | 99.40% | LALUSP<71>HM | — | View |
| GHK-Cu | 01-029-PD-1353 | Vanguard Laboratory | 99.50% | LALUSP<71>HM | — | View |
| TB-500 | 1356 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| 5-Amino-1MQ | 1670 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| 5-Amino-1MQ | 1361 | Vanguard Laboratory | 99.01% | LALUSP<71>HM | — | View |
| CJC-1295/Ipamorelin | 1362 | Vanguard Laboratory | 99.43% | LALUSP<71>HM | — | View |
| CJC-1295 with DAC | 1363 | Vanguard Laboratory | 99.57% | LALUSP<71>HM | — | View |
| BPC-157 | 1673 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| Sermorelin | 1667 | Vanguard Laboratory | 99.12% | LALUSP<71>HM | — | View |
| GLP3-R | 01-073-PD-1353 | Vanguard Laboratory | 99.80% | LALUSP<71> | — | View |
| BPC-157 | 1362 | Vanguard Laboratory | 99.49% | LALUSP<71>HM | — | View |
| BPC-157 | BPC 10mg 120008 | TrustPointe Analytics | 99.42% | USP<71> | — | View |
| HGH Fragment 176-191 | 1200014 | Vanguard Laboratory | 99.37% | LALUSP<71> | — | View |
| BPC-157/TB-500 | — | Vanguard Laboratory | 99.73% | LALUSP<71> | — | View |
| GHK-Cu | 1667 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| Ipamorelin | 01-102-PD-1359 | Vanguard Laboratory | 99.19% | LALUSP<71>HM | — | View |
| DSIP | 1672 | Vanguard Laboratory | 99.09% | LALUSP<71>HM | — | View |
| Tesamorelin | 01-085-PD-1353 | Vanguard Laboratory | 99.22% | LALUSP<71> | — | View |
| GLP2-T | 1664 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| GLP3-R | 1362 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| PNC-27 | 1670 | Vanguard Laboratory | 99.60% | MSLALUSP<71>HM | — | View |
| LL-37 | 1364 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| TB-500 | 1672 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | View |
| SNAP-8 | 01-126-PD-1364 | Vanguard Laboratory | 99.14% | LALUSP<71>HM | — | View |
| MOTS-C | 1673 | Vanguard Laboratory | 99.17% | LALUSP<71>HM | 2026-05-13 | View |
Disclosed Labs